Nonalcoholic steatohepatitis. Other specified inflammatory liver diseases, Nonalcoholic steatohepatitis [NASH]
Conditions
Interventions
Intervention 1: Tab pioglitazone 30 mg once a day. Intervention 2: Tab fenofibrat 200 mg once aday.
Treatment - Drugs
Tab pioglitazone 30 mg once a day
Tab fenofibrat 200 mg once aday
Sponsors
Vice Chancellor for research, Zanjan University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with NAFLD on ultrasonography; ALT more than 1.5 to 5 times the normal range; BMI between 25 to 29.9 Exclusion criteria: Alcoholic hepatitis; systemic or metabolic or inflammatory disease such as diabetes; viral hepatitis; autoimmune hepatitis; secondary fatty liver disease such as drug induced fatty liver disease
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ALT. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: ELIZA.;FBS. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: ELIZA.;Lipid profile. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: ELIZA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improve fatty liver. Timepoint: once at the begining and the second time after twelve weeks. Method of measurement: Specific liver enzyme tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Maryam Jameshorani
Zanjan,University Of Medical Sciences
Outcome results
None listed